ABSTRACT. Objective. To determine whether prenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome (RDS) alters blood pressure in childhood.Design. Prospective follow-up study of a randomized, double-blind, placebo-controlled trial.Setting. National Women's Hospital (Auckland, New Zealand).Participants. Two hundred twenty-three 6-year-old children of mothers who presented with unplanned premature labor and took part in a randomized, controlled trial of prenatal betamethasone therapy for the prevention of neonatal RDS.Intervention. Mothers received 2 doses of betamethasone (12 mg) or placebo, administered through intramuscular injection, 24 hours apart.Main Outcome Measures. Systolic and diastolic blood pressure at 6 years of age.Results. Children exposed prenatally to betamethasone (n ؍ 121) did not differ in systolic or diastolic blood pressure from children exposed to placebo (n ؍ 102) (mean difference: systolic: ؊1.6 mm Hg; 95% confidence interval: ؊4.1 to 0.8 mm Hg; diastolic: ؊0.3 mm Hg; 95% confidence interval: ؊2.5 to 1.8 mm Hg).Conclusion. Prenatal exposure to betamethasone for prevention of neonatal RDS does not alter blood pressure at 6 years of age. Pediatrics 2004;114:e373-e377. URL: http://www.pediatrics.org/cgi/content/full/114/3/e373; prenatal glucocorticoids, respiratory distress syndrome, blood pressure, long-term follow-up.ABBREVIATIONS. RDS, respiratory distress syndrome; CI, confidence interval; RCT, randomized, controlled trial. N eonatal respiratory distress syndrome (RDS) is a major cause of early morbidity and death among the 10% of neonates who are born prematurely. Prenatal glucocorticoid therapy is recommended in the management of preterm labor, for the prevention of RDS, and is very widely used. Such prenatal use of glucocorticoids results in substantial decreases in the rates of neonatal morbidity and death, as well as considerable cost savings. However, the long-term physical effects remain poorly described. 1,2 Furthermore, fetal exposure to excess glucocorticoids has been proposed as one of the core mechanisms explaining the epidemiologic association between low birth weight and subsequent increased blood pressure (the fetal origins of adult disease hypothesis). 3 In a number of animal models, exposure to glucocorticoids before birth results in increased blood pressure in the offspring. 3,4 To date, the data on subsequent blood pressure among human subjects exposed prenatally to glucocorticoids for prevention of RDS have been contradictory. One nonrandomized cohort study found that extremely premature neonates exposed prenatally to glucocorticoids had higher blood pressure in the first 48 hours after birth. 5 Another nonrandomized cohort study of 177 fourteen-year-old children born preterm found that those exposed to glucocorticoids had higher mean systolic and diastolic blood pressures (mean difference: systolic: 4.1 mm Hg; 95% confidence interval [CI]: 0.1 to 8.0 mm Hg; diastolic: 2.8 mm Hg; 95% CI: 0.05 to 5.6 mm Hg). 6 In contrast, a ...